Lionel B. Ivashkiv, MD

A new study by HSS Research Institute scientists identifies a mechanism by which SARS-CoV-2 induces the inflammatory response in COVID-19 patient lungs, so-called “cytokine storm”, that can lead to lasting tissue damage and poor patient outcomes. The...

IpiNovyx Bio featuring Franck Barrat, PhD

Thanks to the generous support of donors, Hospital for Special Surgery (HSS) has announced the funding of nine grants for projects related to the study of COVID-19. These projects reflect the institution’s expertise in basic, translational and clinic...

Scleroderma is a terribly debilitating disease with no effective treatments and the mortality rates are still upwards of 20%-50%, the highest of any rheumatic disease. This disabling autoimmune disorder results in inflammation and fibrosis leading...